市場調查報告書
商品編碼
1423648
微導管的全球市場預測(-2030):按產品類型、設計、應用、最終用戶和地區進行分析Microcatheters Market Forecasts to 2030 - Global Analysis By Product Type, By Design, Application, End User and By Geography |
2023年全球微導管市場規模為8.542億美元,預計2030年將達到13.538億美元,預測期內複合年成長率為6.8%。微導管是細的軟性管,直徑通常為 3 毫米或更小,專為微創醫療手術而設計。
應用範圍從介入放射學中複雜血管結構的導航到治療劑和栓塞劑的精確傳遞。
根據美國衛生統計中心的數據,美國每年有超過 795,000 人中風。此外,根據日本國家癌症中心癌症控制資訊中心的數據,2020 年大約確認了 1,012,000 例癌症病例。
微創手術增加
隨著醫療實踐轉向侵入性較小的干涉措施,微導管在精確進入複雜的解剖結構方面發揮著至關重要的作用。這些纖細、靈活的導管有利於小血管的導航,使醫療專業人員能夠提供治療藥物、進行診斷性血管造影術並進行各種血管介入治療,同時對周圍組織造成的創傷最小。我們將為您提供支持。對微導管的需求是由對更快的患者恢復時間、更少的併發症和更高的手術精度的偏好偏好的,這使得它們成為介入醫學發展的重要工具,並有助於改善患者的治療結果。
開發和製造成本高
複雜的設計、精密的工程以及先進材料的使用導致了高昂的製造成本。微導管的開發需要最尖端科技和對細節的一絲不苟,而且製造過程本身就很複雜。此外,遵守法規和遵守嚴格的品質標準也會增加成本負擔。這些高成本為市場進入帶來了挑戰,並限制了醫療保健提供者和患者對微導管的承受能力。製造商面臨著平衡創新和品質保證的需求與提供具有成本效益的解決方案的需求之間的困境。
門診醫療日益受到重視
門診護理因其成本效益、患者便利性以及在傳統醫院環境之外執行各種醫療程序的能力而受到關注。微導管在向門診醫療的轉變中發揮著重要作用,因為它們允許在血管和其他醫療應用中進行微創診斷和治療性介入。微導管的彈性、精確性和導航能力使其適合在門診環境中使用,在門診環境中,早期復健和縮短住院時間是首要任務。
醫療預算緊張和成本限制
世界各地的衛生系統都受到財政限制的困擾,這可能會阻礙微導管等創新且可能昂貴的醫療設備的引入。開發微導管需要複雜的技術和精度,這可能導致更高的製造成本和更高的價格。在醫療保健提供者面臨最佳化支出壓力的地區,這尤其具有挑戰性。此外,與替代治療方法相比,微導管的成本較高,可能會導致醫療機構選擇更經濟的選擇,進而影響市場滲透率。
COVID-19 的爆發對微導管市場產生了多方面的影響。由於醫療資源的重新分配和安全問題,包括使用微導管的某些干預措施在內的選擇性手術暫時下降,但隨著非緊急服務的恢復,市場已經恢復。此次疫情凸顯了微創手術的重要性,隨著醫療保健系統優先考慮高效和微創手術,推動了對微導管的需求。然而,供應鏈中斷、擇期手術延誤和經濟不確定性也給大流行期間的微導管市場帶來了挑戰。
預計循環系統在預測期內將是最大的
循環系統在微導管市場中佔有很大佔有率。由於其細長的特性和增強的導航性,微導管使醫生能夠精確地進入複雜的血管途徑,支持冠動脈攝影術、血管成形術和栓塞手術。心血管疾病盛行率的上升和對微創技術的日益偏好正在推動對心血管微導管的需求。持續的技術創新和不斷擴大的老年人口正在推動介入心臟病學領域診斷和治療能力的提高,進一步促進市場成長。
醫院和診所部門在預測期內的複合年成長率最高
預測期內微導管市場複合年成長率最高的是醫院和診所。在這些醫療機構中,微導管廣泛用於各種介入手術,例如血管造影術、栓塞和血管介入治療。心血管疾病盛行率的上升和微創手術的成長趨勢推動了需求。微導管使醫療專業人員能夠精確地導航複雜的血管結構,減少患者創傷並改善手術結果。這些設備的持續採用證實了它們在改善醫院和診所的患者照護以及推進介入醫學的重要性。
北美由於其先進的醫療保健和基礎設施、技術創新以及心血管疾病的高盛行率而佔據重要地位,預計在預測期內將保持最大佔有率。微創治療的不斷成長趨勢和需要血管介入治療的人口老化正在推動對微導管的需求。此外,積極的研發活動以及與醫療機構和產業參與者的策略聯盟有助於微導管技術的持續發展。隨著法律規範的建立和醫療專業人員意識的不斷提高,北美仍然是微導管進步和市場成長的關鍵中心。
由於微創手術的快速增加、心血管疾病盛行率的上升以及醫療基礎設施的開拓,亞太地區的微導管市場複合年成長率最高。不斷成長的老年人口,特別是在日本和中國等國家,進一步推動了介入性心臟病學和血管介入治療領域對微導管的需求。醫療技術的進步,加上人們對微創技術優勢的認知不斷提高,正在促進市場的擴張。國內外製造商之間的合作也有助於促進創新和市場滲透。
According to Stratistics MRC, the Global Microcatheters Market is accounted for $854.2 million in 2023 and is expected to reach $1353.8 million by 2030 growing at a CAGR of 6.8% during the forecast period. The Microcatheters are thin, flexible tubes with diameters typically less than 3 millimeters, designed for minimally invasive medical procedures. Their uses range from navigating complex vascular structures in interventional radiology to delivering therapeutic agents or embolic materials precisely.
According to the National Center for Health Statistics, every year, more than 795,000 people in the U.S. have a stroke. According to Center for Cancer Control and Information Services, a part of National Cancer Center, Japan, approximately 1,012,000 cases of cancer were noticed in 2020.
Growing minimally invasive procedures
Medical practices shift towards less invasive interventions, microcatheters play a pivotal role in enabling precise access to intricate anatomical structures. These thin and flexible catheters facilitate the navigation of narrow vessels, aiding healthcare professionals in delivering therapeutic agents, performing diagnostic angiography, and conducting various vascular interventions with minimal trauma to surrounding tissues. The demand for microcatheters is propelled by the preference for reduced patient recovery times, fewer complications, and enhanced procedural precision, making them indispensable tools in the evolving landscape of interventional medicine and contributing to improved patient outcomes.
High development and manufacturing costs
The intricate design, precision engineering, and the use of advanced materials contribute to elevated production expenses. The development of microcatheters requires cutting-edge technologies and meticulous attention to detail, making the manufacturing process inherently complex. Moreover, regulatory compliance and adherence to stringent quality standards further contribute to the cost burden. These high costs can pose challenges for market accessibility, limiting the affordability of microcatheters for both healthcare institutions and patients. Manufacturers face the dilemma of balancing the need for technological innovation and quality assurance with the necessity to offer cost-effective solutions.
Increasing focus on ambulatory care
Ambulatory or outpatient care settings are gaining prominence due to their cost-effectiveness, patient convenience, and the ability to perform various medical procedures outside traditional hospital environments. Microcatheters play a crucial role in the shift towards ambulatory care, as they enable minimally invasive procedures for diagnostic and therapeutic interventions in vascular and other medical applications. The flexibility, precision, and navigational capabilities of microcatheters make them well-suited for use in outpatient settings, where quick recovery and reduced hospital stays are prioritized.
Stringent healthcare budgets and cost constraints
Healthcare systems globally grapple with financial limitations, the adoption of innovative and potentially more expensive medical devices like microcatheters may be impeded. The intricate technology and precision involved in microcatheter development contribute to higher production costs, potentially leading to elevated prices. This can be particularly challenging in regions where healthcare providers are under pressure to optimize expenditures. Moreover, as microcatheters are perceived as costlier compared to alternative treatment methods, healthcare facilities may opt for more economical options, impacting market penetration.
The COVID-19 pandemic has had a multifaceted impact on the microcatheters market. While elective procedures, including certain interventions using microcatheters, experienced temporary declines due to healthcare resource reallocation and safety concerns, the market witnessed a subsequent rebound with the resumption of non-emergency medical services. The pandemic underscored the importance of minimally invasive procedures, boosting the demand for microcatheters as healthcare systems prioritized efficient and less invasive interventions. However, supply chain disruptions, delays in elective procedures, and economic uncertainties have also posed challenges to the microcatheters market during the pandemic.
The cardiovascular is expected to be the largest during the forecast period
The cardiovascular has a significant share in the Microcatheters market. With their slender profiles and enhanced navigability, microcatheters enable physicians to access intricate vascular pathways with precision, supporting procedures such as coronary angiography, angioplasty, and embolization. The rising incidence of cardiovascular diseases, coupled with a growing preference for minimally invasive techniques, propels the demand for cardiovascular microcatheters. Ongoing technological innovations and the expanding geriatric population further contribute to the market's growth, fostering improved diagnostic and therapeutic capabilities in the field of cardiovascular interventions.
The hospitals and clinics segment is expected to have the highest CAGR during the forecast period
The hospitals and clinics have the highest CAGR within the Microcatheters market over the forecast period. These medical facilities extensively utilize microcatheters in various interventional procedures, such as angiography, embolization, and vascular interventions. The demand is driven by the rising prevalence of cardiovascular diseases and the increasing trend toward minimally invasive surgeries. Microcatheters enable healthcare professionals to navigate complex vascular structures with precision, reducing patient trauma and enhancing procedural outcomes. The continual adoption of these devices underscores their importance in improving patient care and advancing the field of interventional medicine within hospital and clinic settings.
North America holds a significant position and expected to hold a largest share over the forecast period due to the region's advanced healthcare infrastructure, technological innovation, and a high prevalence of cardiovascular diseases. The growing trend toward minimally invasive procedures, coupled with an aging population requiring vascular interventions, has propelled the demand for microcatheters. Furthermore, robust research and development activities and strategic collaborations between healthcare institutions and industry players contribute to the continuous evolution of microcatheter technologies. With a well-established regulatory framework and increasing awareness among healthcare professionals, North America remains a key hub for microcatheter advancements and market growth.
The Asia-Pacific region witnessed the highest CAGR in the Microcatheters market due to a surge in minimally invasive procedures, a rising prevalence of cardiovascular diseases, and increasing healthcare infrastructure development. The expanding geriatric population, particularly in countries like Japan and China, further propels the demand for microcatheters in interventional cardiology and vascular interventions. Advancements in healthcare technologies, coupled with a growing awareness of the benefits of minimally invasive techniques, contribute to the market's expansion. Collaborations between local and international manufacturers also play a role in fostering innovation and market penetration.
Key players in the market
Some of the key players in Microcatheters Market include Abbott Laboratories, Inc., Becton, Dickinson and Company, Terumo Corporation, Boston Scientific Corporation, Cardinal Health, Inc., Cardiovascular Systems, Johnson & Johnson, Teleflex Corporation, Medtronic PLC, Stryker Corporation and Merit Medical Systems, Inc.
In October 2023, Johnson & Johnson signed an agreement to acquire Abiomed, a medical device technology company. This acquisition broadens Johnson & Johnson's offerings as well as helps patients.
In July 2023, Stryker announced the acquisition of Vocera Communications, Inc., a company engaged in digital care communication and coordination. Through this acquisition, Vocera provides a supportive and advanced suite to Stryker's Medical division that would improve Stryker's Advanced Digital Healthcare suite and accelerate Stryker's focus on preventing adverse events across the cycle of care.
In December 2022, Boston Scientific Corporation announced the acquisition of Acotec Scientific Holdings Limited, a prominent Chinese medical technology company catering innovative solutions for several interventional procedures. This development has strengthened the company's operating capabilities in the market.